Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders





Income Statement
Balance Sheet
Cash Flow Statement
Segments

Common Size IS
Op Efficiency
Credit Analysis

Y-mAbs Therapeutics, Inc. (YMAB)

Cash Flow Statement

Standardized | As Reported Annual | Quarterly | TTM
  Older >>
In millions, except per share itemsJun-30-23Mar-31-23Sep-30-22Jun-30-22Mar-31-22Dec-31-21Sep-30-21Jun-30-21
   10-Q10-Q10-Q10-Q10-Q10-K10-Q10-Q
Net income    -133.6-135.0-116.8-55.3-38.3-42.3
Depreciation and amortization    0.90.80.80.80.60.6
Stock-based compensation    27.028.519.719.322.821.0
Change in working capital   [+]  18.521.019.812.218.816.5
Other operating activities    -13.9-15.4-19.3-79.6-90.2-88.2
Cash from operations    -101.1-100.0-95.6-102.6-86.4-92.5
   
Capital expenditures    -0.2-0.2-0.3-0.7-0.6-0.6
Purchases of intangible assets       -0.3  
Cash from investing    -0.5-0.5-0.661.061.558.8
   
Option exercises    0.2 0.50.61.91.9
Other cash from financing    0.4 1.01.23.83.8
Cash from financing    0.20.40.5108.3109.6109.6
   
Free cash flow    -101.3-100.2-95.9-103.2-86.9-93.0
        Per share (diluted)    ($2.32)($2.30)($2.20)($2.36)($2.03)($2.21)

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy